Cargando…
Pre-conditioned mesenchymal stem cells: a better way for cell-based therapy
Ischemic heart disease is the major cause of death globally, and a recently developed stem cell transplantation is a promising therapy for myocardial infarction. Mesenchymal stem cells (MSCs) exist in a wide range of tissues, and their differentiation potential and immunoregulatory capacity make the...
Autores principales: | Li, Qing, Wang, Yang, Deng, Zhifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706937/ https://www.ncbi.nlm.nih.gov/pubmed/23739590 http://dx.doi.org/10.1186/scrt213 |
Ejemplares similares
-
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
por: Li, Chenghai, et al.
Publicado: (2020) -
Encapsulation of Mesenchymal Stem Cells: Dissecting the Underlying Mechanism
of Mesenchymal Stem Cell Transplantation Therapy
por: Kin, Kyohei, et al.
Publicado: (2020) -
Mesenchymal stem cells as a potential therapy for COVID-19
por: Liu, Shan, et al.
Publicado: (2020) -
New Models for Large Prospective Studies: Is There a Better Way?
por: Manolio, Teri A., et al.
Publicado: (2012) -
Global Pull Incentives for Better Antibacterials: The UK Leads the Way
por: Outterson, Kevin, et al.
Publicado: (2023)